V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20211795 | 20078684 | 0 | 0 | null | 2018-08-04 | 2018-08-28 | CAPECITABINE + CARBOPLATIN | 02 | null | DOXORUBICIN EMBOLISATION | 100304561 |
| 20211802 | 20078685 | 0 | 0 | Palliative (P) | 2019-11-04 | 2019-11-29 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100423387 |
| 20211804 | 20078686 | 1.78 | 85.5 | Curative (C) | 2016-06-26 | 2016-07-07 | Capecitabine (21days) + Carboplatin | 02 | Y | CAPECITABINE + CARBOPLATIN | 101604259 |
| 20211805 | 20078687 | null | 78.8 | Neo-adjuvant (N) | 2018-01-22 | 2018-01-28 | CISPLATIN + FLUOROURACIL | N | null | CISPLATIN + FLUOROURACIL | 100331048 |
| 20211808 | 20078688 | 0 | 0 | Palliative (P) | 2017-06-23 | 2017-07-14 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101395210 |
| 20211809 | 20078689 | 1.82 | 48.7 | Palliative (P) | 2019-03-21 | 2019-04-17 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100624907 |
| 20211817 | 20078690 | 1.49 | 64.6 | null | 2019-09-04 | 2019-09-04 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100373475 |
| 20211820 | 20078691 | 1.74 | null | Neo-adjuvant (N) | 2016-10-22 | 2016-10-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100402090 |
| 20211823 | 20078692 | 1.63 | 92.3 | null | 2019-01-07 | 2019-01-18 | CAPECITABINE + CARBOPLATIN | 02 | null | CISPLATIN + FLUOROURACIL | 100951053 |
| 20211827 | 20078693 | 1.56 | 92 | Neo-adjuvant (N) | 2017-06-03 | 2017-07-01 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100560414 |
| 20211833 | 20078694 | 1.7 | 51.2 | Palliative (P) | 2017-01-02 | 2017-01-11 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100945657 |
| 20211837 | 20078695 | 1.72 | 54.6 | Neo-adjuvant (N) | 2018-02-16 | 2018-02-20 | Capecitabine (21days) + Carboplatin | N | N | TRIAL UNSPECIFIED | 100946633 |
| 20211839 | 20078696 | 1.61 | 106.5 | Palliative (P) | 2017-12-18 | 2017-12-19 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101017504 |
| 20211847 | 20078697 | 1.7 | 60 | Palliative (P) | 2018-06-14 | 2018-06-14 | CISPLATIN + FLUOROURACIL + RT | N | N | CISPLATIN + FLUOROURACIL | 100214508 |
| 20211848 | 20078698 | 1.76 | 51.2 | 03 | 2017-01-20 | 2017-01-20 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100868022 |
| 20211851 | 20078699 | null | null | Curative (C) | 2018-07-29 | 2018-08-14 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100788626 |
| 20211852 | 20078700 | 1.79 | 81 | Neo-adjuvant (N) | 2018-03-31 | 2018-04-15 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101774406 |
| 20211854 | 20078701 | 1.59 | 74.5 | Curative (C) | 2017-01-18 | 2017-01-20 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101826464 |
| 20211860 | 20078702 | 1.61 | 77.65 | Palliative (P) | 2020-01-19 | 2020-02-01 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 101586720 |
| 20211865 | 20078703 | 1.87 | 46.3 | Neo-adjuvant (N) | 2020-01-04 | 2020-01-05 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100593907 |
| 20211870 | 20078704 | 1.71 | 42.1 | Palliative (P) | 2017-04-26 | 2017-05-02 | CISPLATIN + FLUOROURACIL + RT | 2 | N | CISPLATIN + FLUOROURACIL | 100018303 |
| 20211876 | 20078705 | 1.77 | 65 | Palliative (P) | 2016-12-28 | 2017-01-04 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 100405042 |
| 20211880 | 20078706 | 1.61 | 45 | null | 2019-09-07 | 2019-09-14 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100223552 |
| 20211882 | 20078707 | 1.87 | 69.5 | Palliative (P) | null | 2019-09-14 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100953706 |
| 20211884 | 20078708 | 1.76 | 62.7 | null | 2016-03-28 | 2016-04-04 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101523670 |
| 20211893 | 20078709 | 1.71 | 85 | Palliative (P) | 2019-09-12 | 2019-09-19 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 101733428 |
| 20211895 | 20078710 | 1.81 | null | Curative (C) | 2018-07-15 | 2018-07-22 | Capecitabine (21days) + Carboplatin | 02 | Y | CISPLATIN + FLUOROURACIL | 100988310 |
| 20211905 | 20078711 | null | null | Neo-adjuvant (N) | 2017-09-11 | 2017-09-12 | Capecitabine (21days) + Carboplatin | N | N | DOXORUBICIN EMBOLISATION | 101266229 |
| 20211906 | 20078712 | 1.54 | 86.2 | null | 2018-01-16 | 2018-01-28 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100017059 |
| 20211908 | 20078713 | 1.68 | 95 | Curative (C) | 2019-05-01 | 2019-06-04 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100119396 |
| 20211912 | 20078714 | 1.76 | 50.75 | Curative (C) | 2017-05-05 | 2017-05-15 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100785021 |
| 20211913 | 20078715 | 0 | 0 | Palliative (P) | 2017-12-09 | 2017-12-10 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101486396 |
| 20211914 | 20078716 | 1.73 | 75 | null | 2018-10-11 | 2018-11-30 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101601724 |
| 20211918 | 20078717 | 1.58 | 95.2 | null | 2017-07-12 | 2017-07-16 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101277461 |
| 20211921 | 20078718 | 1.81 | 63.9 | Neo-adjuvant (N) | 2018-05-26 | 2018-05-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100758038 |
| 20211923 | 20078719 | 1.79 | 51.2 | Neo-adjuvant (N) | 2017-11-06 | 2017-11-08 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101421338 |
| 20211928 | 20078720 | 1.83 | 92.7 | Curative (C) | 2019-05-31 | 2019-06-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101453338 |
| 20211933 | 20078721 | 0 | 0 | 03 | 2018-10-18 | 2018-10-20 | Capecitabine (21days) + Carboplatin | N | null | DOXORUBICIN EMBOLISATION | 101245948 |
| 20211938 | 20078722 | 1.67 | 86.3 | Palliative (P) | null | null | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101044780 |
| 20211939 | 20078723 | 0 | 0 | null | 2019-09-30 | 2019-10-19 | Capecitabine (21days) + Carboplatin | 02 | null | DOXORUBICIN EMBOLISATION | 100965422 |
| 20211942 | 20078724 | null | 51.7 | 03 | 2019-10-20 | 2019-11-07 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100783192 |
| 20211944 | 20078725 | 1.67 | 0 | Palliative (P) | 2018-06-19 | 2018-06-23 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101212621 |
| 20211948 | 20078726 | 1.62 | 124.4 | Palliative (P) | 2017-01-31 | 2017-01-31 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100865890 |
| 20211951 | 20078727 | 1.54 | 110.6 | Palliative (P) | null | 2018-06-24 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101522520 |
| 20211952 | 20078728 | 1.54 | 82.6 | Palliative (P) | 2018-08-26 | 2018-08-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101303147 |
| 20211957 | 20078729 | 1.58 | 66.7 | Palliative (P) | 2016-05-05 | 2016-05-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101518051 |
| 20211958 | 20078730 | 0 | 0 | Palliative (P) | 2016-12-17 | 2016-12-30 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 100615501 |
| 20211960 | 20078731 | 1.67 | 71.3 | Palliative (P) | 2019-03-28 | 2019-03-28 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101749462 |
| 20211961 | 20078732 | 1.17 | 65.45 | Curative (C) | 2017-09-16 | 2017-09-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100833154 |
| 20211965 | 20078733 | 1.71 | 74.3 | Neo-adjuvant (N) | 2017-08-01 | 2017-08-08 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 100604903 |